Pexidartinib in the Management of Advanced Tenosynovial Giant Cell Tumor: Focus on Patient Selection and Special Considerations

Vaynrub, A., Healey, J. H., Tap, W., & Vaynrub, M. (2022). Pexidartinib in the Management of Advanced Tenosynovial Giant Cell Tumor: Focus on Patient Selection and Special Considerations. OncoTargets and Therapy, Volume 15, 53–66. https://doi.org/10.2147/ott.s345878
Authors:
Anna Vaynrub
John H Healey
William Tap
Max Vaynrub
Affiliated Authors:
Anna Vaynrub
Columbia Affiliation:
Author Keywords:
csf1
gct-ts
pvns
colony-stimulating factor 1
giant cell tumor of tendon sheath
hepatotoxicity
pigmented villonodular synovitis
radiotherapy
synovectomy
elink
Publication Type:
Article
Unique ID:
10.2147/ott.s345878
PMID:
35046667
DOI:
10.2147/ott.s345878
Journal:
OncoTargets and Therapy
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: